Citadel Advisors »

Harpoon Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Harpoon Therapeutics shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Harpoon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Harpoon Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Harpoon Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.8M 686k 11.37
2023-09-30 $199k 49k 4.03

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Harpoon Therapeutics

Cormorant Asset Management
Commodore Capital
RA Capital Management
Franklin Resources
Artal Group
Vanguard Group
Soleus Capital Management
Blackstone Group
Citadel Advisors
Lion Point Capital
Kennedy Capital Management
Goldman Sachs Group
Citigroup
Two Sigma Investments
Standard Life Aberdeen

View all funds holding Harpoon Therapeutics